Berino, Ma Corazon E.

HRN: 23-82-41  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2023
MUPIROCIN 2%, 15G (TUBE)
10/05/2023
10/08/2023
TOPICAL
2% Small Amount
BID
Blistered Lesion
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: